ANN ARBOR STAGE IV MANTLE CELL LYMPHOMA

Clinical trials for ANN ARBOR STAGE IV MANTLE CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new ANN ARBOR STAGE IV MANTLE CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for ANN ARBOR STAGE IV MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New drug combo tested in aggressive blood cancer

Disease control Not yet recruiting

This early-stage study aims to find a safe and effective dose of a new drug called glofitamab when given alongside standard chemotherapy for people with previously untreated mantle cell lymphoma, a type of blood cancer. The main goal is to check for side effects and determine the…

Matched conditions: ANN ARBOR STAGE IV MANTLE CELL LYMPHOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

ANN ARBOR STAGE IV MANTLE CELL LYMPHOMA

Get alerted when new ANN ARBOR STAGE IV MANTLE CELL LYMPHOMA trials appear

New drug combo tested in aggressive blood cancer